Public Policy
Bradley Merrill Thompson, an FDA-watcher, lawyer and occasional MobiHealthNews guest contributor, joins the MobiHealthNews team for a closer look at what the FDA has been up to around digital health and AI.
The HIMSS Media team gives a recap of recent headlines surrounding the FDA, COVID-19 and new digital health software products.